Is NCT06747949 recruiting?

Yes, NCT06747949 is currently recruiting. This sjögren's syndrome study is enrolling participants at 30 locations.

What is the status of NCT06747949?

NCT06747949 is currently recruiting. This is a Clinical Trial trial for sjögren's syndrome sponsored by Amgen. Status verified Feb 12, 2026 via ClinicalTrials.gov.

Where is NCT06747949 enrolling participants?

NCT06747949 has 30 active sites including Avondale, Arizona; Flagstaff, Arizona; Gilbert, Arizona and 27 more locations.

Who is eligible for NCT06747949?

This sjögren's syndrome trial is targeting 844 participants. Detailed eligibility criteria including age requirements and medical history are listed on this page.

Who can participate in this Sjögren's Syndrome study?

Eligibility varies by study, but generally includes adults diagnosed with Sjögren's Syndrome who meet specific medical criteria. Complete the interest form above to learn if you may qualify.

Is the study available in Flagstaff, Arizona?

Yes! This study has active research sites in Flagstaff, Gilbert, Glendale. When you express interest, you'll be connected with the site nearest to you.

What are the benefits of joining a clinical trial for Sjögren's Syndrome?

Participants often receive: access to new treatments before they're widely available, close monitoring by medical professionals, study-related care at no cost, and the opportunity to contribute to medical research.

⚡Your ready-to-use recruitment solution: IRB-compliant, SEO-optimized website that automatically routes qualified patient leads to your clinical study (14-day free trial, then $44/mo)

NCT06747949 RECRUITINGIRB Ready

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

Express Your Interest Today

Interested in learning more? Complete the form below.

First Name *

Last Name *

Email Address *

Phone Number *

ZIP Code *

Age Range *

Preferred Location

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

No-Cost Study Care
Advance Medical Science
Contribute to groundbreaking research
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel (varies by study)
Help Others
Benefit future patients

*Compensation varies by study. Confirm details with coordinator.

Simple Process

1Submit this form
2Phone screening
3In-person assessment if eligible
4Begin participation

About This Study

The primary objective of this study is to evaluate the long-term safety and tolerability of dazodalibep.

Who Can Participate

Inclusion Criteria

Participants are eligible to be included in the study only if all the following criteria apply:

Participant has provided informed consent before initiation of any study specific activities/procedures.

Must have been eligible to receive and have received IP (dazodalibep or placebo) and completed the study (through Week 48) in one of the phase 3 SS dazodalibep studies (HZNP-DAZ-301, or HZNP-DAZ-303).

Must be able to receive Dose 1 of this LTE study at the Week 48 Visit (+28 days) for the prior pivotal phase 3 SS dazodalibep studies (HZNP DAZ-301, or HZNP DAZ-303).

Exclusion Criteria

Participants are excluded from the study if any of the following criteria apply:

Clinically significant active infection at Day 1, in the opinion of the Investigator, including ongoing and chronic infection requiring antibiotics or antiviral medication.

Planned participation in another clinical study with an IP or procedure during the LTE study. Other investigational proced

❓ Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility during the screening process.

Study Details

📋

Study Type

INTERVENTIONAL

👥

Target Enrollment

844 participants

⚧

Gender

ALL

🏢

Sponsor

Q:What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Q:Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Q:Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Q:Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

Q:How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Still have questions? Our study coordinators are here to help.

Ready to Make a Difference?

Express your interest in this groundbreaking clinical trial

🔒 Secure · 🏥 Expert Care

Find More Sjogrens Syndrome Trials by City

Browse all sjogrens syndrome clinical trials in these cities — not just this study.

Flagstaff, Arizona Gilbert, Arizona Glendale, Arizona Bradenton, Florida Clearwater, Florida Tampa, Florida

Browse More Trials by Condition

Sjogrens Syndrome Trials Myalgic Encephalomyelitis Trials All Conditions →

Looking for Sjögren's Syndrome Treatment in Flagstaff?

Join others in Arizona exploring innovative treatment options through clinical research

Sjögren's Syndrome Treatment Options in Flagstaff, Arizona

If you're searching for Sjögren's Syndrome treatment in Flagstaff, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Flagstaff, Gilbert, Glendale and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Sjögren's Syndrome. All study-related care is provided at no cost to participants.

Local Sites

3 locations in Arizona

Now Enrolling

Up to 844 participants

Quick Start

Screening available now

Why Consider a Clinical Trial for Sjögren's Syndrome?

Potential Benefits

✓Access to new treatment approaches before public availability
✓Close monitoring by experienced medical professionals
✓Study-related care provided at no cost
✓Contribute to medical research for Sjögren's Syndrome

What to Expect

→Initial screening to determine eligibility
→Regular check-ups and monitoring visits
→Possible compensation for time and travel
→You can withdraw at any time

Frequently Asked Questions About This Sjögren's Syndrome Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06747949. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.